Search for Clinical and Behavioral Research Studies

Ann & Robert H. Lurie Children’s Hospital of Chicago and Stanley Manne Children’s Research Institute lead or participate in hundreds of research studies that seek answers about diseases, better treatments, preventative care, and more. Many of these studies can be found in this database. Use the finder to learn more. 
 

Filters

Search Results List

Showing 11 - 20 of 876 results
Matching clinical studies
Study Title Keywords Status
Study Title
ID: NCT04074265 PI: Vineeta T Swaroop
Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy
Status
Study Title
ID: NCT04485104 PI: Priyamvada Tatachar
Safety, Pharmacokinetics, and Exploratory Efficacy Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) Compared With Standard of Care Antiseizure Medication, in Participants Age 1 Month to <12 Months of Age With Tuberous Sclerosis Complex
Status
Recruiting
Study Title
ID: NCT03532542 PI: Nancy L Kuntz
An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
Status
Study Title
ID: NCT04825587 PI: Neeraj Patel
The Pediatric ALL Evaluation and Trial
Status
Study Title
ID: NCT04475926 PI: Vamshi K Rao
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
Status
Recruiting
Study Title
ID: NCT04089566 PI: Nancy L Kuntz
Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
Status
Recruiting
Study Title
ID: NCT04042025 PI: Nancy L Kuntz
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
Status
Study Title
ID: NCT01826071 PI: Rebecca L Carl
Comparison of Three Treatments for Lower Extremity Apophysitis
Status
Study Title
ID: NCT04488133 PI: Nancy L Kuntz
A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec
Status
Recruiting
Study Title
ID: NCT04554914 PI: Sonali Chaudhury
A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases
Status
Recruiting